Moreover, circATP2C1 expression in prostate cancer cells did not change significantly after RNase R treatment, whereas mRNA expressions of linear ATP2C1 and GAPDH were significantly reduced (Figure 2C). This evidence concerns the gene ATP2C1 and prostate carcinoma.